Ecolab laundry disinfectant receives U.S. EPA approval for claim of effectiveness against Sars-Cov-2

June 5, 2020

Ecolab’s AdvaCare Disinfectant has received the first approval given by the U.S. Environmental Protection Agency (EPA) for a laundry disinfectant and oxidizer emerging viral pathogen claim as effective against SARS-CoV-2, the virus that causes COVID-19. 

AdvaCare Disinfectant is an EPA-registered laundry disinfectant – registration number 1677-193 – and the concentrated formulation is permitted for use in commercial and industrial laundry operations. 

“AdvaCare Disinfectant delivers the highest level of cleanliness for reusable textiles, and the emerging viral pathogen claim for SARS-CoV-2 will provide additional assurance to commercial laundries and the customers they serve,” said Greg Thorsen, Ecolab senior vice president and general manager, Textile Care North America. “This is the first laundry antimicrobial additive with an emerging viral pathogen claim that can be dosed directly into the wash process in both tunnel washers and large conventional commercial laundry machines.” 

The current U.S. EPA-approved master label for AdvaCare Disinfectant now contains use directions for emerging viral pathogens, such as SARS-CoV-2, and Clostridium difficile (newly named Clostridioides difficile) at an attainable daily use level for all textiles laundered in a commercial laundry. The disinfectant is listed on the EPA’s LIST N website for products that can be used against SARS-CoV-2. 

In addition to protecting against harmful organisms, AdvaCare Disinfectant outperforms chlorine and peroxide for disinfecting, whiteness, sustainability and overall effectiveness. It also helps extend the usability of textiles compared to alternative oxidizers. 

“We are focused on developing high-performing and sustainable products that clean right the first time,” added Thorsen. “Our innovative disinfection technology is setting a new standard in the commercial laundry industry.” 

Ecolab has the announcement.  

More COVID-19 coverage HERE.